Australia markets closed

AVXL Oct 2024 7.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.65000.0000 (0.00%)
As of 09:38AM EDT. Market open.
Full screen
Previous close1.6500
Open1.6500
Bid0.0000
Ask0.0000
Strike7.00
Expiry date2024-10-18
Day's range1.6500 - 1.6500
Contract rangeN/A
Volume5
Open interestN/A
  • Simply Wall St.

    Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?

    We feel now is a pretty good time to analyse Anavex Life Sciences Corp.'s ( NASDAQ:AVXL ) business as it appears the...

  • GlobeNewswire

    Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

    NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) diseases, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of

  • Associated Press Finance

    Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

    NEW YORK (AP) — Anavex Life Sciences Corp. AVXL) on Tuesday reported a loss of $12.2 million in its fiscal third quarter. On a per-share basis, the New York-based company said it had a loss of 14 cents.